Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Quanterix and Innovita said China’s NMPA approved the Quanterix HD-X and SR-X instruments plus four neurology biomarker assay kits. The approvals expand access to SIMOA-based testing in China and support the companies’ commercialization arrangement.
Quanterix said China’s NMPA approved its HD-X and SR-X instruments and four SIMOA neurology biomarker kits via partner Innovita.
Innovita received NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker kits in China. The companies said the approvals expand access to SIMOA-powered blood-based testing.